Compare TG Therapeutics Inc (TGTX) vs Toyota Motor Corp (TM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TG Therapeutics Inc vs Toyota Motor Corp — how do they compare? TG Therapeutics Inc trades at $54 (market cap $8.26B), while Toyota Motor Corp trades at $180.4 (market cap $212.22B). The key difference: Toyota Motor Corp is far larger — about 25.7× TG Therapeutics Inc's market cap, and Toyota Motor Corp pays a 3.51% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| TGTX | TM | |
|---|---|---|
Market Cap | $8.26B | $212.22B |
Sector | Health | Consumer Cyclical |
52-Week High | $59.06 | $248.29 |
52-Week Low | $26.39 | $166.50 |
Enterprise Value | $8.50B | $376.42B |
Dividend Yield | — | 3.51% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →About Toyota Motor Corp
Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →
